Xiling Shen, PhD Professor & Chief Scientific Officer, Terasaki Institute for Biomedical Innovation, Chief Executive Officer, Xilis Inc. "Developing in silico, in vitro, and in vivo platforms for precision oncology" A PDF of the seminar flyer can be downloaded here.